Suicide gene-therapy strategies are promising approaches in treating various diseases such as cancers, atherosclerosis, and graft-versushost-disease. Here, we describe the development of a new effector gene based on inducing functional caspase 8, the initiator caspase in the death-receptor pathway. We constructed vectors encoding a constitutively active form of human caspase 8 (CC8), and demonstrated the efficient killing of a variety of cell types in transfection and lentivirus-transduction assays. We then analyzed the ability to control the apoptotic activity of a caspase 8-derived construct through the ARIADt homodimerization system (FKC8), a system shown to be extremely effective in several cellular models upon retroviral and lentiviral gene transfer. Similarly, two transcription-regulation systems, muristerone-regulated and Tet-On, were tested to control the expression of CC8. The homodimerization-regulated system FKC8 was shown to be the most efficient system with low background activity in noninduced conditions. In the presence of a dimerizer, it was as active as the activated Tet-On system. From our data, we conclude that the dimerizer-dependent human caspase 8 represents a highly inducible and very powerful system to eradicate transduced cell populations. In addition to its application in experimental gene therapy, this variant may be highly useful for mechanistic research related to apoptosis.
S
uicide gene therapy is a promising strategy for the treatment of diseases as diverse as cancers, atherosclerosis and graft-versus-host-disease (GvHD). The archetypical effector system used in gene therapy relies on the expression of the herpes simplex virus thymidine kinase gene (HSV-tk) followed by ganciclovir administration. 1 Activation of ganciclovir by HSV-tk causes cell death in a variety of cell types. Ganciclovir-phosphateinduced apoptosis involves the mitochondrial pathway, with the death receptor pathway playing little or no role. 2, 3 A major obstacle for the application of HSV-tk and similar prodrug-activating enzymes is the induction of immune responses against HSV-tk-expressing cells. 4, 5 Although immune responses are not problematic in genetherapy treatment of certain types of cancer, there are cases where immune response should be kept as low as possible, for example, in GvHD. Another drawback of HSV-tk-based therapy is its requirement for active cell proliferation. Quiescent or slowly dividing cells are not responsive to such treatment. Therefore, the development of alternative suicide gene systems is of evident interest. 6 In that sense, strategies relying on endogenous apoptosis machinery are particularly attractive. Upon activation, caspases have been shown to be highly effective in killing cells independently of their proliferative status, and thus have been envisioned as a new way in which to induce apoptosis in gene therapy strategies. 7 In attempting to elucidate the mechanism of caspase 8 activation, Lenardo's laboratory generated a constitutively active form of caspase 8, consisting of a fusion of the transmembrane domain of CD8 with the catalytic portion of caspase 8 (from here on denoted as CC8). 8 The transmembrane domain of CD8 allows for the oligomerization of caspase 8 at the membrane, which is essential for the conversion of procaspase 8 to an active form of caspase 8. This chimera CC8 is highly efficient in directing apoptosis. 8 Furthermore, this fusion of human proteins is less likely to trigger immune responses than viral or bacterial suicide gene products. The modified form of caspase 8 therefore appears as an attractive proapoptotic factor that could be considered as a suicide gene. However, the highly efficient apoptotic activity of this constitutively active form of caspase 8 requires tight control of its expression.
The aim of this study is to evaluate the efficiency of the inducible caspase 8 construct that relies on the homodimerization system derived from human FKBP12 protein (FK506-Binding Protein). 9 The idea is that the active domain of caspase 8 is fused to a CBD (chemical inducers of dimerization-binding domain), a modified FKBP domain in this study, so that dimerization (and thus activation) occurs following the addition of the inducer of dimerization (CID), AP20187. 10, 11 Several chemical inducers of dimerization-inducible caspases, as well as specific variants of CID and CBD, have been known to regulate cellular apoptosis. [12] [13] [14] [15] We also investigated the ability of two widely used transcriptional regulatory systems, the Tet-On system, 16 and the Muristerone system 17 to control the activity of the constitutively active form of caspase 8 (CC8) .
In this report, we show that the control of caspase 8 dimerization allows for a tightly regulated induction of apoptosis. The system has low leakiness under noninduced conditions and is highly efficient upon induction. Furthermore, we successfully evaluated the proapoptotic fusion protein in a retroviral and lentiviral context in several cellular models. We propose this dimerizationregulated caspase 8 as a powerful humanized system for suicide gene applications, as well as for mechanistic research related to apoptosis.
Materials and methods

Cell culture
293T, MEF, 911, and MCF7 (kindly provided by AG Jochemsen) cells were grown in high glucose DMEM supplemented with 10% fetal bovine serum (Gibco-BRL) and penicillin/streptomycin. Jurkat cells were grown in RPMI supplemented with 10% fetal bovine serum (Gibco-BRL) and penicillin/streptomycin. All cells were maintained at 371C in a humidified atmosphere of 5% CO 2 in air. Percentage of cells undergoing phenotypic change was determined by direct counting of several photographed fields.
Constructs
We have included a schematic representation of the critical constructs in Figures 2a (Tet-On and Muristeroneinducible systems), and 2c (FKC8). A detailed description of all plasmids (about 20) can be obtained upon request.
Tetracycline-regulated system: The pUHC13-3 (tetracycline-responsive luciferase reporter) and pUHD10-3 (tetracycline-responsive cloning vector) were kindly provided by H Bujard (Zentrum fur Molekulare Biologie der Universitat Heidelberg, Heidelberg, Germany). pTet-On (rtTa expressing vector) was purchased from Clontech. pBabe-TetOp-CC8-pA was constructed by inserting the TetOp sequences (from pUHD10-3), followed by CD8-caspase8 (CC8) (from pcEFL-CD8-caspase8) and a polyadenylation sequence from SV40, into a pBabe retroviral vector encompassing a modified polylinker sequence. Cloning orientation is such that Tet-Op transcription is in opposite orientation to the LTR.
Muristerone-regulated system: plasmids pVgRXR (muristerone-regulated activator and RXR) and pIND (muristerone-responsive promoter) were obtained from InVitrogen. pIND-Luc was constructed by inserting the pGEM-Luc XhoI/BamHI fragment in pIND. pIND-CC8 was constructed by inserting HindIII/NotI CD8-caspase 8 (CC8) fragment from pcEFL-CD8-caspase 8 in the corresponding sites of pIND.
Dimerization system: caspase 8 was amplified by PCR from plasmid (FpK)3-Flice (kindly provided by V Dixit) with the oligonucleotides 5 0 -cgcactagtagtgaatcacagactttggac-3 0 and 5 0 -cgcactagtatcagaagggaagacaagttt-3 0 , thereby introducing two flanking SpeI sites. The resulting fragment, verified by sequencing, was inserted in the SpeI site of pC4-MFv2E, which was kindly provided by ARIADt, to generate pC4-MFvE-caspase 8 (FKC8).
PRK5-p35 was constructed by inserting the p35 BamHI fragment from pPRM-35K-ORF, kindly provided by P Friesen in the pRK5 vector. GFP in Figure 3 was encoded by peGFP-N1 (Clontecht).
Transfections
293T cells were transfected at 50% confluency by the calcium phosphate coprecipitation procedure. Transfections in 96-well dishes were performed with a total of 70 ng DNA/well, 1 mg in 24-well dishes, and 5 mg in 60 mm plates.
Induction
Tet-On was induced by adding 1 mg/ml Doxycycline (Clontecht), the Muristerone-regulated system by adding 1 mM Muristerone (InVitrogent), and dimerization by adding 10 nM AP20187 (ARIADt).
Lentiviruses, construction, production, and transduction
The vectors used in our study are the so-called selfinactivating (SIN) vectors, [18] [19] [20] which lose the activity of the promoter located in the 5 0 LTR upon replication and integration into the genome of the host cells. Expression of the transgene is under the control of an internal CMV promoter: this will be the only mRNA transcribed.
The vector plasmids were all derivatives of the pRRL-cPPT-X-PRE-SIN. 19, 21 Plasmids pRRL-cPPT-CMV-GFP-PRE-SIN (here named pLV-CMV-GFP), pRRL-cPPT-CMV-LUC-PRE-SIN (here named pLV-CMV-Luc), and pRRL-cPPT-CMV-IRES-GFP (here named pLV-CMV-IRES-GFP) were constructed with cytomegalovirus promoter driving green fluorescent protein or luciferase reporter genes directly or indirectly via an Internal Ribosome Entry Site (IRES). Then, plasmids pRRL-cPPT-CMV-CC8 (here named pLV-CMV-CC8), pRRL-cPPT-CMV-FKC8 (here named pLV-CMV-FKC8), and pRRL-cPPT-CMV-CC8-IRES-GFP (here named pLV-CMV-CC8-IRES-GFP) and pRRL-cPPT-CMV-FKC8-IRES-GFP (here named pLV-CMV-FKC8-IRES-GFP) were generated by insertion of CC8 or FKC8 inserts in pLV-CMV or pLV-CMV-IRES-GFP constructs, respectively.
The vectors were produced as described previously. 22 Briefly, the lentiviral backbone containing the gene of interest, and the three ''helper'' plasmids (encoding HIV1 . This value has been converted to an infectious titer using the approximation that 1 ng of p24 equals 2500 infectious units. 19 For transduction, viral supernatants were added to fresh medium supplemented with 8 mg/ml polybrene (Sigma), and the cells were incubated overnight. The next day, the medium was replaced with fresh medium. Transduction efficiency was analyzed 2-3 days posttransduction.
We used the technique to transfer a reporter gene as a surrogate parameter of cell viability. The method is derived from earlier work by Reiser et al, 23 who demonstrated that lentiviral cotransduction does work efficiently without affecting the transfer efficiency of either of the vectors.
Luciferase activity
Luciferase activities were determined by luminometry using the Promega Luciferase Assay Reagent.
WST assay: Cell viability was assessed with the WST-1 colorimetric assay (Roche diagnostics, Almere, The Netherlands) according to the manufacturer's instructions.
FACS analysis
For FACS analyses, MCF7 were trypsinized gently, the volume was increased by adding PBS supplemented with 1% fetal bovine serum, and the cells were kept on ice. The samples were analyzed with a FACScan flow cytometer (Becton Dickinson). GFP fluorescence was detected using a 530/30 nm band-pass filter (FL1 channel) following excitation with an argon ion laser source at 488 nm. Using a forward scatter (FSC)/side scatter (SSC) representation of events, a region was defined in order to exclude cellular debris from the analysis. A number of events/FL1 (which reflects the fluorescence intensity) histogram was then established according to this region, and percentages of GFP-positive cells were determined in comparison to the negative control (untreated cells). Data analysis was performed using CellQuest 3.1 software (Becton Dickinson). For each sample, 5000 events were collected.
Statistical analysis
In Figures 1, 4 , and 5, statistical analyses were performed using the website www.graphpad.com (unpaired t test), and values of Po0.05 (significant) are marked with an asterisk (*).
Western blot and apoptosis assay
Cells were treated with lysis buffer: 20 mM Tris-Cl (pH 7.5), 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 1 mM EDTA, 1% Triton X-100, 0.5% NP40, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM orthovanadate, 1 mg/ml leupeptin, 1 mM PMSF. Samples for Western analyses were prepared by boiling protein extracts with sample buffer (10% glycerol, 2% SDS, 60 mM Tris-Cl (pH 6.7), 2.5% b-mercaptoethanol, and 2.5% bromophenol blue from a 1:20-diluted saturated solution) for 5 minutes at 1001C. Samples were then analyzed on 10% polyacrylamide-SDS gels (30% acrylamide-bisacrylamide (37.5:1); Bio-Rad) overlaid by a 5% stacking gel (30% acrylamide-bisacrylamide (37.5:1); BioRad). Proteins were transferred to Immobilon-P (Immobilon-P transfer membrane (polyvinylidene difluoride); Millipore, Etten-Leur, The Netherlands) and visualized by standard protocols with anticleaved PARP (1:1000, Cell Signaling technology #9541) (kindly provided by P Verrijzer (Department of Molecular Cell Biology, Leiden University, Leiden, The Netherlands)), and anti-Actin (1:500, clone C4; ICN Biomedicals, Inc., Zoetermeer, The Netherlands) as primary antibody. All antibodies were diluted in TBST (0.2% Tween 20, 150 mM NaCl, and 10 mM Tris) with 5% nonfat dried milk (Protifar Plus; Nutricia BV, Zoetermeer, The Netherlands).
Results
Modified caspase 8 as a suicide gene
During the analysis of caspase 8 processing, Lenardo et al engineered the CD8-caspase 8 chimera, a constitutively active form of caspase 8 8 (Fig 1a) . This chimeric protein activated apoptosis and led to cell death. Some preliminary tests were performed by transient transfection in 293T cells, a transformed human kidney cell line extensively used in apoptosis studies. [24] [25] [26] We transferred either a CC8 or a CD8 encoding plasmid, together with a GFP tracer, and observed that cells cotransfected with the CD8 and the GFP expression vectors did not display any phenotypic differences as compared to cells transfected with GFP alone (data not shown). This indicates that the CD8 transmembrane domain used to bring the caspase 8 domain to the membrane does not affect the transfected cells. In contrast, coexpression of CC8 clearly affected the cells, since very few cells were GFP positive, and those were rounded and presented membrane blebbing reminiscent of cells undergoing apoptosis. Identical results were obtained using transfected murine NIH3T3 fibroblasts (data not shown).
To investigate whether the CC8 system could be used in a more applied and physiological situation, the chimeric form CC8 was further evaluated in a lentiviral context. In a first assay, the GFP reporter gene was used as a read out. The cells were transduced with LV-CMV-GFP lentiviral vector in a first round of transduction and 2-3 hours later with either LV-CMV-Luc or LV-CMV-CC8 in a second round of transduction. We observed massive cell Caspase 8-derived suicide gene F Carlotti et al death when CC8 was expressed (Fig 1b) . The same phenomenon is clearly visible in cells transduced with LV-CMV-Luc followed by LV-CMV-CC8 (Fig 1c, upper panel) with a 75% decrease in luciferase activity (Fig 1c, lower left panel). Furthermore, cell death evaluated by a WST viability assay shows a 55% decrease (Fig 1c, lower right panel).
To verify that the apparent cell death that we observed is indeed the result of apoptosis, we tested the ability of an established apoptosis inhibitor to interfere with CC8 action. Z-VAD.fmk is a synthetic cell-permeable fluoromethylketone, 27 which forms a covalent inhibitory complex with caspase 8. The result depicted in Figure 1b (right panel) demonstrates that Z-VAD.fmk inhibits CC8-induced cell death. A baculovirus p35 expression vector was tested as well, with the same protective effects on CC8 expressing cells (data not shown). Taken together, these data demonstrate that cell death following the expression of the CC8 chimeric construct is due to apoptosis. One way to regulate caspase 8 activity is to control its transcription. We tested two of the most widely used transcriptional regulatory systems: the tetracycline-regulated system, and the ecdysone-regulated system (described in Fig 2a) . We first determined the optimal concentration of inducers in order to obtain maximum responses (data not shown). Based on these results, we transfected 293T cells in 96-well plates with 20 ng of a luciferase encoding reporter construct (TetOp-Luc or E/ GRE-Luc), and a range of 0-50 ng (0, 0.8, 1. 6, 3.1, 6.2, 12.5, 25, and 50) of plasmids coding for tTa (pTet-On) or pVgRXR (muristerone-dependent activator). Empty vector plasmid was added as necessary to keep the total amount of transfected plasmid constant at 50 ng per well. This was performed under induced (doxycycline/muristerone) or noninduced conditions (EtOH). The results obtained under our 96-well plate transfection conditions were striking (Fig 2b) . First, the absolute level of expression obtained with the Tet-On system is one log higher than that observed with the muristerone system under induced conditions (about 180,000 luciferase units versus 18,000). Second, the leakiness of the Tet-On system is quite dramatic, since it is actually higher than the maximum level of induction seen with the muristerone system (see 0 ng pTet-On in the presence of Dox). The leakiness observed is not the result of Tet contaminating the culture media, since our sera were tested for their lack of tetracycline. Intriguingly, we observed that doxycycline already activates luciferase activity by itself. One hypothesis could be that doxycycline treatment activates NF-kB via an increase of superoxide generation as previously described, 28 and it is well known that the CMV promoter does contain some binding sites specific to the NF-kB transcription factor family. 29 Third, the leakiness of the muristerone system is very limited. The conclusion of this comparison is that the absolute induction ration (induced/ noninduced) of the Tet-On system is quite modest (fourto seven-fold), while that of the muristerone system is more than 1 log better (about 80-fold), despite a much lower level of overall expression.
Efficient regulation of caspase 8 activation through controlled dimerization
The goal of this study is to evaluate the efficiency of caspase 8-derived constructs in inducing apoptosis in a controllable manner. For this purpose, we investigated another approach to regulate caspase 8 activation, derived from the strategy developed by Muzio et al. 13 In these experiments, the transmembrane domain of CD8 was replaced by an inducible dimerization system derived from the human protein FKBP12 (the ARIADt ARGENTt Regulated Homodimerization system). Inducible dimerization of the protein of interest relies on the small synthetic ligand, AP20187. We fused the 262-amino-acid long C-terminal portion of human caspase 8 to a repetition of two modified domains of the human protein FKBP12 present in the pC4-MFv2E plasmid, thus creating pFKC8 (Fig 2c) . The synthetic protein FKC8 is also fused to a myristoylation signal in order to mimic recruitment to the membrane. A dose-response curve was performed with increasing amounts of AP20187 dimerizer (0.001, 0.01, 0.05, 0.1, 1, 10, and 100 nM) in a transient cotransfection experiment using 293T cells, with luciferase being used as a read out. As illustrated on Figure 2d , a subnanomolar (0.1 nM) concentration of AP20187 is sufficient to induce a 95% decrease of luciferase activity, when the LC50 is about 0.008 nM in this experiment. The addition of up to 100 nM AP20187 on control cells transfected with a luciferase reporter alone had no negative effect on cell viability as reflected by luciferase activity (Fig 2d upper panel) . The reduction ratio of cell viability following induced dimerization of FKC8, as compared to control cells not expressing FKC8, is visualized on the lower panel of Figure 2d . This shows that cell death driven by induced FKC8 is highly efficient.
Direct comparison of Tet-On, Muristerone, and inducible dimerization in regulating the suicide activity of caspase 8-derived products CC8 was subcloned under the control of the Tet-On and muristerone systems. These constructs were cotransfected in 293T cells together with a GFP tracer, and the percentage of apoptotic cells was evaluated by cell counting. Since we showed that the basal level of expression of these systems was not equivalent, we first examined the response of the cells in the presence of expression vectors under nonstimulated conditions (Fig 3a) . Quite dramatically, 91% of the GFP-positive cells transfected with Tet-On-controlled CC8 displayed a clear proapoptotic phenotype 48 hours post-transfection. This reflects the high level of leakage detected in our previous test (Fig 2b) . Accordingly, cells transfected with muristerone-controlled CC8 did not display such a dramatic phenotype after 48 hours, but still presented 23% rounded cells. Their growth was slower than the control cells, which showed only 2% rounded cells. These results were further amplified after 24 additional hours in culture, since no increase in cell number was seen, and almost all the cells exhibited a rounded phenotype with clear membrane blebbing using the Tet-On system (see inset in Fig 3a) . The muristerone system barely allowed for the survival of the cells. Furthermore, upon induction (Fig 3b) , we obtained results in agreement with those reported in Figure 2b : the highest absolute level of expression of CC8 under the Tet-On system resulted in the elimination of virtually all cells, while a few rounded cells were still visible when CC8 was expressed under the control of the muristerone system. Despite the low level of leakage that we observed with the muristerone system, it is clear that this level of CC8 leakage is nevertheless sufficient to significantly affect cell growth. This demonstrates that a very tight system is required in order to use a caspase 8-derived suicide strategy.
We next evaluated the efficiency of the FKC8 chimera in the same 293 T cell system. As shown in Figure 3 , in the Caspase 8-derived suicide gene F Carlotti et al absence of the dimerizer, the cells exhibited a much less altered phenotype as compared to that observed with the muristerone-regulated system after 72 hours in culture. It must be noted however that FKC8-expressing cells displayed significantly less abundant GFP-positive cells compared to control cells after 72 hours, and that the GFP signal was not as strong. This suggests that a minimal basal level of caspase 8 activation nevertheless exists, interfering with normal cell growth even in the absence of added dimerizer. Upon induction, the dimerization system was very effective in killing the cells, since only very few GFP-positive cells were still detected, displaying a weak signal, and all were floating. The killing activity of the different constructs following induction was confirmed and quantified by measuring the luciferase activity from the cotransfected CMV-Luc expression vector 24 hours postinduction. Based on phenotypic changes and cell numbers, the FKC8 construct was more efficient than all the other constructs tested in inducing cell death (Fig 3c) .
FKC8 is highly effective in driving controlled cell suicide in a retroviral and lentiviral context FKC8 was subcloned in a retroviral vector upstream of an IRES-GFP cassette. Phenotypical observations and quantification of total amounts of proteins both demonstrated that mouse fibroblasts (MEF cells) transduced with a retroviral vector expressing FKC8 and treated with the dimerizer AP20187 were 10-fold less abundant than those observed in the noninduced or mock transduced cells (data not shown). This indicates that cells transduced by the retrovirus were indeed lost, but only after induction.
In the next series of experiments, we evaluated FKC8 efficiency in a lentiviral context using several other cellular models: growth-arrested diploid human fibroblasts VH10 cells (Fig 4a) , human breast cancer cell line MCF7 (Fig 4b) , and human T cells Jurkat (Fig 4c) . Pilot experiments (data not shown) were first performed to determine the minimal amount of virus necessary to transduce all the cells with the CMV-GFP lentiviral vector (about 40 ng p24 per 10 5 cells). The same amount of CMV-Luc lentiviral vector was used, and the decrease in luciferase activity reflected cell death after two rounds of transduction with the indicated lentiviral constructs. We observed that the expression of FKC8 in the presence of AP20187 efficiently killed the cells in all three cellular models (43, 71, and 35% decrease in cell numbers for VH10, MCF7, and Jurkat cells, respectively). This effect could be blocked by Z-VAD. One should note however that in all the cell lines tested, CC8 seems to be more efficient (75, 98, and 71% decrease). As expected, no decrease in luciferase activity was observed after lentiviral-mediated expression of FKC8 in the absence of the dimerizer (Luc þ FKC8/EtOH/DMSO), compared to the control (Luc þ GFP/DMSO). As previously described, we observed that Z-VAD treatment enhanced Jurkat cell survival, probably by increasing the amount of uncleaved RIP. 30 Finally, MCF-7 cells have been shown not to express caspase 3. 31 Since our caspase 8-derived constructs are at least as efficient in inducing apoptosis in these cells as they are in the other cell lines, it is clear that the apoptotic process involved is indeed independent of caspase 3.
FKC8-driven cell suicide is a bona fide apoptotic process and transduced cells keep their suicide potential with time
To confirm that the cell death observed in FKC8-expressing cells following AP20187 addition is due to bona fide apoptotic activity, we monitored the cleavage of PARP (Fig 5a) , a 116 kDa nuclear poly (ADP-ribose) polymerase, which is one of the main cleavage targets of several caspases, and thus a good marker of cells undergoing apoptosis. 32 Cleavage of human PARP releases an 89 kDa fragment. Western blot analysis of lysates from cells expressing the constitutively active form CC8 (CC8/DM) or the inducible form FKC8 in the presence of the dimerizer (FKC8/AP) in both cases resulted in the apparition of a band of the expected size. Since no signal could be detected in the absence of AP20187 (FKC8/Et-DM), the apoptotic process appears to be tightly dependent upon the presence of the dimerizer.
In order to confirm the absence of toxicity of FKC8, MCF7 cells were transduced with a lentiviral vector coexpressing an IRES-GFP cassette (LV-CMV-FKC8-IRES-GFP) to monitor proviral expression throughout time. An empty vector (LV-CMV-IRES-GFP) was transduced in parallel as a control. We observed that 25 days after transduction (the longest time tested), the percentage of GFP-positive cells remained stable (Fig 5b) . We thus assumed that FKC8 was still expressed in the same proportion of cells. After 25 days, the FKC8-transduced cells were treated with 10 nM AP20187. Figure 2 Tet-On and Muristerone transcription regulatory systems: (a) Schematic outline of the tetracycline (Tet-On) and muristerone-regulated systems (muristerone). The Tet-On system relies on a transcriptional activator rtTa (reverse tetracycline-controlled transcriptional activator), a fusion protein of a mutated form of the Tet repressor and the transactivator domain of the viral protein VP16 from the herpes simplex virus, and a construct containing the gene of interest under the control of a promoter driven by the Tet operator sequences. The transactivator rtTa will be able to bind the TetOp sequences and activate expression of the transgene, only in the presence of tetracycline. In the muristerone-regulated system, the transactivator (VgEcR) is composed of a fusion between VP16 and the N-terminal domain of Ecdysone receptor modified in such a way that, it is only in the presence of cofactor RXR and muristerone, that it can bind a synthetic response element E/GRE (hybrid of Ecdysone response element and glucocorticoïdes response element), and activate the transgene expression. (b) 293T cells were transfected in 96-well plates with the indicated amounts (0-50 ng) of pTet-On (Tet-On) together with 20 ng of Tet-responsive luciferase reporter, pUHC13-3 (TetOpLuc), and pVgRXR (Mur.), together with 20 ng of muristerone-responsive luciferase reporter, pIND-Luc (E/GRE-Luc). Adjustments to obtain equal amounts of DNA were performed with a control plasmid. At 48 hours after transfection, cells were lysed and luciferase activity was determined in conditions of noninduction (EtOH) and induction (1 mg/ml doxycycline (Tet-On), 1 mM muristerone (Mur)). Each value is a mean of at least eight points (upper panels). Induction ratio is the ratio between the (ratio of luciferase activities in the presence of inducer (Dox or muristerone) and in the absence of inducer) and (the luciferase activities with the inducers but without any plasmid encoding the transactivators (0 ng pTet-On on pVgRXR)) (lower panels). (c) FKC8 is a fusion protein containing an amino-terminal myristoylation signal (M), two copies of a modified form of human FKBP (amino-acid 36 mutated in Valine) (FKBP*), the catalytic portion of human caspase 8, and a hemagglutinin tag (HA) at the carboxyterminal end. In the presence of inducer (AP20187), the modified FKBP domains will dimerize at the membrane (because of the myristoylation signal), and activate the caspase 8, leading to the death of the cell (w). (d) 293T cells were transfected in 24-well plates with 10 ng of pLV-CMVLuc and 1 mg of pLV-CMV-IRES-GFP (CMV) or pLV-CMV-FKC8-IRES-GFP (FKC8) in the presence of 0 (100%), 0.001, 0.01, 0.05, 0.1, 1, 10, and 100 nM AP20187. At 2 days after transfection, cells were lysed and assayed for luciferase activity. Values are means of three independent experiments (left panel). Reduction ratio is the ratio between luciferase activities when FKC8 is expressed and luciferase activities when CMV is expressed (right panel). One hundred percent has been set arbitrarily to 0 nM AP20187. 
Discussion
Suicide gene therapy is a promising approach to cancer gene therapy. We chose to evaluate the potential of caspase 8 as a therapeutic gene. Caspase 8 is an initiator caspase in the death receptor pathway. Its position at the top of the caspase cascade permits the triggering of both extrinsic and intrinsic apoptosis pathways. 33, 34 Following apoptotic stimulation, inactive procaspase 8 is converted into active procaspase 8. This obligatory activation step is bypassed in the CC8 and FKC8 constructs used in our study. Hence, the constitutively active CC8 and the activated FKC8 form of caspase 8 are expected to trigger apoptosis when ectopically expressed and activated. FKC8 acts as a conditional apoptotic factor, since it is based on the ARIADt ARGENTt Regulated Homodimerization system. This controls the dimerization of a membrane-bound caspase 8 protein through the addition of a small synthetic ligand, AP20187. Shariat et al 7 reported low efficiency of a previous homodimerizationregulated caspase 8. However, their construct differs from ours in two major ways. First, the more recent mutant version of FKBP domains that we used has a much higher affinity for 3rd generation dimerizers like AP20187. Second, Shariat et al used a soluble form of caspase 8 that lacks sequences required for membrane anchoring such as the myristoylation signal present in our construct. It has been clearly shown that membrane oligomerization is a crucial step for caspase 8 autoactivation 8 through induced proximity, 13, 35 and that soluble caspase 8 is only poorly active.
In order for our caspase 8-based strategy to have any potential therapeutic sense, the proapoptotic activity of our constructs must not be inhibited by the cells being targeted. The only mechanisms for caspase 8 inhibition reported so far involve either viral inhibitors (CrmA, 36 p35 37,38 ) or synthetic peptides, 27 none of which exist under normal physiological conditions. Cellular factors interfering with FLICE/procaspase 8 activation step, such as cFLIP (FLICE-inhibitory protein), 39, 40 have also been reported. However, since the FKC8 chimera is not dependent upon caspase 8 cleavage for its activation, FLIP-like inhibition of caspase 8 involving competition with structural homologs lacking proteolytic activity becomes irrelevant. Furthermore, the role of the long form of c-FLIP (cFLIP L ) has recently been clarified further: the cFLIP L -caspase8 heterodimer functions as an active protease. 41, 42 Ectopic expression of cFLIP L enhances procaspase 8 processing and thereby promotes apoptosis. Conversely, a decrease in cFLIP L level inhibits the apoptotic process. Taken together, this indicates that a putative interaction of cFLIP with our construct may in fact be beneficial to its proapoptotic activity.
Some inhibitors, such as the IAP family members (''Inhibitor of Apoptosis Protein''), can protect downstream targets from caspase 8. 43 The prototype of this family is XIAP, which is specific for caspases 3, 7, and 9. 44 The coexistence of high basal levels of apoptotic effectors (particularly of caspases 3 and 8) and high levels of apoptotic inhibitors (XIAP and Survivin) in human tumor cells has recently been reported. 45 MCF7, one of the cell lines used in our study, is a human breast cancer model. Our results demonstrate that the ectopic expression of a constitutively active (CC8) or inducible form (FKC8) of caspase 8 in MCF7 cells, even in a lentiviral context, is sufficient to bypass these apoptotic inhibitors, thus validating our strategy.
In designing a vector that specifically induces cell death by apoptosis, one must consider the intrinsic activity of the proapoptotic product being expressed, as well as its level of expression. We showed that the expression of CC8 and FKC8 induces massive cell death in transient expression experiments, as well as in retroviral and lentiviral contexts, in all the cellular models tested. We further verified that the cell death observed was indeed the result of an apoptotic process (inhibition with caspase inhibitors and detection of cleaved PARP). We observed that in all experiments, the constitutively active form CC8 is more efficient than the inducible FKC8 form in killing cells. This suggests that the inducible homodimerization domain can be further improved. Fusion of additional modified FKBP domains, and/or addition of a linker between these FKBP domains to alleviate possible sterical hindrance, could be some paths to explore toward that goal.
Since the only way to control CC8 apoptotic activity is through its expression, we compared two widely used transcriptional regulation systems: the tetracyclineregulated system, and the muristerone-regulated system. This comparison revealed clear limitations of both systems in driving the expression of a potent proapoptotic product. The tetracycline-regulated system Tet-On is commonly used by molecular biologists after clonal selections. Indeed, the level of expression of the gene of interest is dependent upon their loci of integration. It is thus possible to select clones that best fit what the investigator is looking for. However, our approach using retro-and lentiviruses is closer to what would be found in a therapeutic situation, where the targeted cell population is transduced as a whole. Therefore, clonal selection is of no relevance, and a range of different levels of expression of the construct used has to be considered. Unfortunately, in the absence of clonal selection, the Tet-On system displays quite high levels of expression under noninduced conditions, clearly revealed in luciferase experiments, and confirmed in CC8 assays (Fig 3) . This renders the system an unlikely candidate for controlling the expression of a potent proapoptotic factor. In other words, a high basal level of expression would be detrimental to cell growth, even under repressed conditions. Assays relying on tetracycline regulation recurrently face this problem, and additional locking systems have had to be developed in attempts to keep this leakage down. [46] [47] [48] The muristerone-regulated system presents a much lower level of leakage in our luciferase assay, and in this sense would be more suited than the tetracycline system for controlling the expression of a proapoptotic factor. However, its absolute level of expression is quite modest, Caspase 8-derived suicide geneas seen in our luciferase assays, and confirmed by the low percentage of dying green cells when driving the expression of CC8, even in our transient transfection system, where levels of expression are at their best. It is thus likely that under therapeutic conditions, this level would be too low for a significant induction of apoptosis in a heterogeneous cell population. To conclude on that aspect, each of these two systems has specific advantages as well as inconveniences, and should be carefully chosen depending on the type of regulation being investigated. In our situation, however, neither would be ideal.
We found that the homodimerization-regulated chimera FKC8 is a good alternative to controlling a caspase 8-based proapoptotic system. Indeed, it shows the lowest apoptotic activity under repressed conditions, while maintaining a potent apoptotic activity in the presence of the AP20187 inducer used at nM concentrations. The apparent absence of undesired apoptotic activity in the absence of AP20187 in our retroviral and lentiviral assays may appear surprising in view of the results observed in 293 T cells (Fig 3) . This is likely the reflection of differences in protein expression levels in the two systems, since CaP cotransfection is known to allow for unphysiologically high levels of expression in 293T cells. However, even in these transient transfection conditions, no cleaved PARP signal was detected by Western blot analyses performed 36 hours post-transfection, suggesting that the apoptotic process was kept minimal. Since FKC8 appeared the best way to regulate caspase 8 activity, we decided to investigate the stability of FKC8 expression in transduced MCF7 cells. No toxicity following FKC8 transduction could be detected after more than 3 weeks, while FKC8 apoptotic activity was revealed as soon as the dimerizer was added. Our results demonstrate the necessity of having both a tight system, to avoid deleterious leakage under nonstimulated conditions, and a high absolute level of induction, to allow for a biological effect in cells where transgene expression may be limited. We described in this work an efficient strategy for the controlled destruction of cells. But obviously, efficient targeting strategies will be equally necessary in order to localize the expression of our caspase 8-derived candidates, and thus to test its therapeutic potential in an organism.
Despite its utility in certain cancer therapeutic strategies, immune response is generally to be avoided in clinical applications. A totally ''humanized'' suicide system is thus necessary. Both the Tet-responsive and the muristerone-responsive transactivators, derived from bacteria and drosophila, respectively, are expected to be immunogenic. Indeed, this has been reported at least for the Tet-On system after introduction into non-human primates. 49 The homodimerization-regulated caspase 8 is derived from human proteins, and is thus less likely to trigger any significant immune response. FKC8 is also an attractive alternative to the widely used HSV-tk/ganciclovir suicide system. It would be particularly well suited in the treatment of patients treated for GvHD. [4] [5] [6] In addition, controlled suicide of slow or nondividing cells, which are refractory to HSV-tk/ganciclovir treatment, would be possible with FKC8, since caspase 8-induced apoptosis does not rely on DNA replication. The recent and elegant work by Xie et al 50 using a modified caspase 9 as an AP20187 inducible proapoptotic factor to successfully eliminate prostate-derived cancer cells LNCaP goes in the same direction.
FKC8 could also be a useful tool to further clarify the ''induced proximity model'' for caspase 8 activation, 13 which has recently been attributed to a dimerization event. 51, 52 Combination of retroviral and lentiviral vectors could permit the study of a larger panel of cellular models.
Finally, it would be of great interest to study the effects of the loss of a specific cell type. Using this method with a former version of homodimerization-regulated caspase, Wencker et al have recently demonstrated that myocyte apoptosis can be a causal mechanism of heart failure. 53 Mouse models for different human disorders in which apoptosis is involved could also be generated using such a strategy. For example, Mallet et al 54 recently used a similar approach with caspase 3 specifically expressed in the liver of transgenic mice.
